Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

LASIX ONYU

FUROSEMIDE

Standard Dose
80MG/2.67ML (30MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LASIX ONYU is listed in Drugs@FDA under application 217294 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FUROSEMIDE Form and strength SOLUTION;SUBCUTANEOUS - 80MG/2.67ML (30MG/ML) Sponsor SQ INNOVATION Submission history Latest submission status date: 2025-10-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview LASIX ONYU is listed in Drugs@FDA under application 217294 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FUROSEMIDE Form and strength SOLUTION;SUBCUTANEOUS - 80MG/2.67ML (30MG/ML) Sponsor SQ INNOVATION Submission history Latest submission status date: 2025-10-07 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.